Elis stock trades at EUR 21.86 as analysts target EUR 29.82

Elis stock was trading at EUR 21.86 on Euronext Paris at 9:24 a.m. CEST on September 29, 2026, down 0.64 percent from the prior close. The share remains EUR 0.88 above its 52-week low of EUR 20.98 and EUR 6.48 below its 52-week high of EUR 28.34.

Analysts keep targets above EUR 29.82

Zonebourse reported on September 22, 2026, that 15 of 16 analysts covering Elis held positive views, with an average target of EUR 29.82. That target is 36.47 percent above the September 29 price.

The same report showed a sharper market contrast: Elis had lost 13.5 percent since the start of 2026 and 22 percent over three months by September 22. The figures place the current quotation near the lower end of its annual range, even as the analyst consensus remains constructive.

Revenue growth and employee plan

According to Ideal Investisseur on September 8, 2026, Elis reported Q1 2026 revenue of EUR 1,277 million, up 5.4 percent from the prior-year period. The same report cited organic growth close to 10 percent in Latin America and a marked increase in new contract signatures.

Elis also launched its 2026 employee share ownership plan on September 3, 2026, according to GlobeNewswire. The offer applies a 30 percent discount to the reference price and includes one matching share for every 10 shares subscribed.

The subscription period runs from September 15 to October 1, 2026, while the capital increases are scheduled for completion on November 10, 2026. The offer therefore adds a defined corporate event while the stock trades close to its yearly low.

Third-quarter revenue is scheduled

Elis lists third-quarter 2026 revenue for October 28, 2026, at 5:45 p.m. CEST on its investor-relations page. For investors, the next operating update will test whether the 5.4 percent Q1 revenue growth rate is continuing across the group.

Elis was valued at EUR 4.7 billion on September 29, 2026, with 6,463 shares traded at the recorded intraday snapshot. The market is balancing recent price weakness against recurring-service revenue, positive analyst positioning and the upcoming revenue release.